New Palestine, IN, United States of America

Richard Earl Higgs, Jr


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 87(Granted Patents)


Location History:

  • New Palestine, IN (US) (1999 - 2000)
  • Zionsville, IN (US) (2023)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Richard Earl Higgs, Jr.: Innovator in Immune-Mediated Disease Therapies

Introduction

Richard Earl Higgs, Jr. is a notable inventor based in New Palestine, IN (US). He has made significant contributions to the field of immunology, particularly in developing therapies for immune-mediated diseases. With a total of 4 patents, Higgs has focused on innovative solutions that target specific interleukins.

Latest Patents

Higgs' latest patents include groundbreaking work on compounds and methods targeting human interleukin-19. These inventions encompass therapeutic antibodies, pharmaceutical compositions, and diagnostic applications. They are particularly useful in treating immune-mediated diseases such as psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma, and diabetic nephropathy.

Career Highlights

Richard Higgs is currently associated with Eli Lilly and Company, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from various immune-related conditions.

Collaborations

Higgs has collaborated with esteemed colleagues, including Robert John Konrad and Brian Jeffrey Nickoloff. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the medical field.

Conclusion

Richard Earl Higgs, Jr. stands out as a dedicated inventor whose work in targeting interleukin-19 has the potential to transform treatments for immune-mediated diseases. His contributions to the field are invaluable and continue to pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…